Questionable Universal Validity of PAX3/FOXO1 Fusion Gene Status As Molecular Marker for Improvement of Risk Stratification in Rhabdomyosarcoma Therapy-Reference-Cited by-同舟云学术

Questionable Universal Validity of PAX3/FOXO1 Fusion Gene Status As Molecular Marker for Improvement of Risk Stratification in Rhabdomyosarcoma Therapy

Published:2012-11-10 Issue:32 Volume:30 Page:4039-4040
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Stegmaier Sabine¹,Bielack Stefan S.²,Leuschner Ivo³,Klingebiel Thomas⁴,Koscielniak Ewa¹

Affiliation:

1. Olgahospital, Klinikum Stuttgart, Stuttgart, Germany

2. Olgahospital, Klinikum Stuttgart, Stuttgart; University Children's Hospital Muenster, Muenster, Germany

3. Institute for Pediatric Pathology, Kiel Pediatric Tumor Registry, University of Kiel, Kiel, Germany

4. University of Frankfurt (Main), Frankfurt, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.43.5628

Reference12 articles.

1. PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

2. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?

3. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.

4. PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group

5. Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe;European Journal of Cancer;2022-09

2. Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers;Genes;2019-08-30

3. Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?;Virchows Archiv;2018-02-21

4. Update on molecular findings in rhabdomyosarcoma;Pathology;2017-04

5. Prognostic value of PAX3/7–FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2015-10